Form 4: ESTA Director Edward Schutter Acquires Shares

Establishment Labs Holdings Inc. Director Edward J. Schutter acquired 257 common shares at $72.88 each, increasing his direct beneficial ownership to 138,272 shares.

Summary

• Edward J. Schutter, a Director of Establishment Labs Holdings Inc. (ESTA), acquired 257 common shares.
• The transaction occurred on December 31, 2025, at a price of $72.88 per share.
• These shares were received in lieu of a quarterly cash retainer payment, as per his prior election under the Issuer's Outside Director Compensation Policy.
• The common shares were issued pursuant to the Issuer's 2018 Equity Incentive Plan.
• Following this transaction, Mr. Schutter directly beneficially owns 138,272 common shares.

Sentiment

Score: 6

Explanation: The filing indicates a director's acquisition of shares as part of compensation, which is generally viewed as a minor positive signal of alignment with shareholder interests, though not indicative of a discretionary purchase based on new information.

Positives

• Director Edward J. Schutter increased his direct beneficial ownership in Establishment Labs Holdings Inc. by acquiring 257 common shares.
• The acquisition demonstrates the director's continued participation in the company's equity, aligning his interests with shareholders.
• The transaction was part of a pre-elected compensation policy, indicating a structured approach to director remuneration that includes equity.

Negatives

• No specific negative aspects are disclosed in this Form 4 filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The transaction reflects the Reporting Person's prior election to receive common shares in lieu of a quarterly cash retainer payment, in accordance with the Issuer's Outside Director Compensation Policy.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common across all publicly traded companies. It reflects standard corporate governance practices where directors may elect to receive equity as part of their compensation, aligning their interests with shareholders. It does not provide specific insights into broader industry trends for Establishment Labs Holdings Inc.

Comparison to Industry Standards

• The practice of compensating directors with equity, often through an equity incentive plan, is a common industry standard for publicly traded companies, including those in the medical technology or healthcare sector where Establishment Labs Holdings Inc. operates.
• Many companies, such as Medtronic (MDT) or Boston Scientific (BSX), utilize similar director compensation policies that allow for equity grants or elections in lieu of cash to foster long-term alignment.

Corporate Governance

Related Party Transactions

• Director Edward J. Schutter, a related party, acquired 257 common shares from Establishment Labs Holdings Inc. as part of his compensation.

Stakeholder Impact

• Shareholders may view the director's increased equity stake as a positive sign of management's commitment and alignment with long-term company performance.
• Employees are not directly impacted by this specific transaction, but the underlying equity incentive plan could be relevant to broader employee compensation structures.

Next Steps

• No specific future actions, events, or milestones are mentioned in this Form 4 filing.

Key Dates

Keywords

Establishment Labs Holdings Inc., ESTA, Form 4, Insider Transaction, Director Compensation, Equity Incentive Plan, Share Acquisition, Corporate Governance